GAIN THERAPEUTICS, INC Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
GAIN THERAPEUTICS, INC (GANX) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $49.16 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2026-08-11
- 2026-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $49.16K.
- 2026-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $49.85K.
- 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $50.56K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2026-06-30 | $49.16K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $49.85K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $50.56K 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |